Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: Critical remarks

Clinical and Experimental Immunology

Volumn 179, Issue 1, 2015, Pages 5-10

  Rekvig, O P ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Autoimmunity; Autoinflammatory disease; Inflammation; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; DOUBLE STRANDED DNA ANTIBODY; ANTINUCLEAR ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; CHROMATIN; DISEASE CLASSIFICATION; DNA STRUCTURE; HUMAN; IMMUNOGENICITY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; AUTOIMMUNE DISEASES; BLOOD; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; BIOMARKERS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84931442578     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12296     Document Type: Article

References (40)

1. Tan EM, Cohen AS, Fries JF etal. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-1277.
2. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
3. Petri M, Orbai AM, Alarcon GS etal. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64:2677-2686.
4. Stollar BD. Antibodies to DNA. CRC Crit Rev Biochem 1986; 20:1-36.
5. Stollar BD. Immunochemistry of DNA. Int Rev Immunol 1989; 5:1-22.
6. Widom J. A relationship between the helical twist of DNA and the ordered positioning of nucleosomes in all eukaryotic cells. Proc Natl Acad Sci USA 1992; 89:1095-1099.
7. Rekvig OP, Moens U, Sundsfjord A etal. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest 1997; 99:2045-2054.
8. Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 1989; 142:1482-1486.
9. Gilkeson GS, Ruiz P, Howell D, Lefkowith JB, Pisetsky DS. Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA. Clin Immunol Immunopathol 1993; 68:283-292.
10. Desai DD, Krishnan MR, Swindle JT, Marion TN. Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J Immunol 1993; 151:1614-1626.
11. Cerutti ML, Zarebski LM, de Prat GG, Goldbaum FA. A viral DNA-binding domain elicits anti-DNA antibodies of different specificities. Mol Immunol 2005; 42:327-333.
12. Sundar K, Jacques S, Gottlieb P etal. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun 2004; 23:127-140.
13. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14:426-430.
14. Fredericks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996; 9:18-33.
15. Madaio MP, Hodder S, Schwartz RS, Stollar BD. Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol 1984; 132:872-876.
16. Rekvig OP, Nossent JC. Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms? Arthritis Rheum 2003; 48:300-312.
17. Rekvig OP, Bendiksen S, Moens U. Immunity and autoimmunity induced by polyomaviruses: clinical, experimental and theoretical aspects. Adv Exp Med Biol 2006; 577:117-147.
18. Edgington SM, Stollar BD. Immunogenicity of Z-DNA depends on the size of polynucleotide presented in complexes with methylated BSA. Mol Immunol 1992; 29:609-617.
19. Chen C, Prak EL, Weigert M. Editing disease-associated autoantibodies. Immunity 1997; 6:97-105.
20. Chen C, Nagy Z, Radic MZ etal. The site and stage of anti-DNA B-cell deletion. Nature 1995; 373:252-255.
21. Marion TN, Tillman DM, Jou NT. Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB×NZW)F1 mouse. J Immunol 1990; 145:2322-2332.
22. Shlomchik M, Mascelli M, Shan H etal. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990; 171:265-292.
23. Lafer EM, Rauch J, Andrzejewski C Jr etal. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 1981; 153:897-909.
24. Richmond TJ, Davey CA. The structure of DNA in the nucleosome core. Nature 2003; 423:145-150.
25. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8A resolution [see comments]. Nature 1997; 389:251-260.
26. Griffith J, Bleyman M, Rauch CA, Kitchin PA, Englund PT. Visualization of the bent helix in kinetoplast DNA by electron microscopy. Cell 1986; 46:717-724.
27. Carroll P, Stafford D, Schwartz RS, Stollar BD. Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. J Immunol 1985; 135:1086-1090.
28. Limpanasithikul W, Ray S, Diamond B. Cross-reactive antibodies have both protective and pathogenic potential. J Immunol 1995; 155:967-973.
29. Mostoslavsky G, Fischel R, Yachimovich N etal. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 2001; 31:1221-1227.
30. Zhao Z, Weinstein E, Tuzova M etal. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum 2005; 52:522-530.
31. Amital H, Heilweil M, Ulmansky R etal. Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol 2005; 175:5516-5523.
32. Qureshi F, Yang Y, Jaques SM etal. Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients. Am J Reprod Immunol 2000; 44:136-142.
33. Krishnan MR, Wang C, Marion TN. Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice. Kidney Int 2012; 82:184-192.
34. Van Ghelue M, Moens U, Bendiksen S, Rekvig OP. Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation. J Autoimmun 2003; 20:171-182.
35. Dieker JW, van der Vlag J, Berden JH. Triggers for anti-chromatin autoantibody production in SLE. Lupus 2002; 11:856-864.
36. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010; 6:280-289.
37. Rock KL, Benacerraf B, Abbas AK. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med 1984; 160:1102-1113.
38. Voll RE, Roth EA, Girkontaite I etal. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum 1997; 40:2162-2171.
39. Andreassen K, Moens U, Nossent H, Marion TN, Rekvig OP. Termination of human T cell tolerance to histones by presentation of histones and polyomavirus T antigen provided that T antigen is complexed with nucleosomes. Arthritis Rheum 1999; 42:2449-2460.
40. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177:1367-1381.